Hyperkalemia: Clinical Trials

4 trials for Hyperkalemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Terminated 4

Follow Hyperkalemia: new trials by email Literature Review of Hyperkalemia trials Research Report on Hyperkalemia

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients With Hyperkalaemia
Sodium Zirconium Cyclosilicate (SZC), Enhanced dietary advice, Standard dietary advice including K+ restriction. - Hyperkalaemia
Phase 4TerminatedAstraZeneca32021-08-172023-01-19
Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management
Patiromer Powder for Oral Suspension [Veltassa], Placebo - Hyperkalemia
Phase 4TerminatedComprehensive Research Associates1152020-10-082023-08-31
Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Add-On
Spironolactone - Type2 Diabetes, Hyperkalemia
Phase 4TerminatedUniversity Hospitals Cleveland Medical Center82018-07-172022-05-16
Safety and Efficacy of Sodium Polystyrene Sulfonate in Hyperkalemia
Sodium polystyrene sulfonate, Silicified microcrystalline cellulose - Hyperkalemia
Phase 4TerminatedZS Pharma, Inc.322013-05-012014-09-03

Narrower conditions

Emergencies (1)

Broader conditions

Metabolic Diseases (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Water-Electrolyte Imbalance (4)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

patiromer (2)  ·  Bulk Drugs (1)  ·  Spironolactone (1)  ·  Suspensions (1)  ·  polystyrene sulfonic acid (1)  ·  sodium zirconium cyclosilicate (1)

Sponsors

AstraZeneca (1)  ·  Comprehensive Research Associates (1)  ·  University Hospitals Cleveland Medical Center (1)  ·  ZS Pharma, Inc. (1)

Countries

United States (4)

Top investigators

Eric Wittbrodt, PharmD, MPH (1)  ·  Henrik Rasmussen, MD (1)  ·  Sanjay Rajagopalan, MBBS (1)

Results publications

PMID 37308268, PMID 41730555